Kezar Life Sciences, Inc. (KZR) Financials
KZR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 199.1 million | 30.0 million |
| 2023-12-31 | 221.2 million | 33.7 million |
| 2023-09-30 | 249.3 million | 33.3 million |
| 2023-06-30 | 263.4 million | 31.1 million |
KZR Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | -22.9 million | 3.4 million |
| 2023-12-31 | -19.0 million | 3.2 million |
| 2023-09-30 | -20.3 million | 6.6 million |
| 2023-06-30 | -23.0 million | 4.0 million |
KZR Net Income
No data available :(
KZR Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 179.8 million | - | 8.2 million |
| 2023-12-31 | 201.4 million | - | 8.9 million |
| 2023-09-30 | 218.2 million | - | 9.5 million |
| 2023-06-30 | 236.6 million | - | 10.2 million |
KZR Shares Outstanding
KZR Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | - | 17.2 million | 6.5 million | 260000 |
| 2023-12-31 | 1000 | 22.6 million | 5.8 million | 280000 |
| 2023-09-30 | 136000 | 23.7 million | 8.8 million | - |
| 2023-06-30 | 1.4 million | 21.0 million | 5.8 million | - |
KZR Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | - | 260000 |
| 2023-12-31 | -5.4 million | 280000 |
| 2023-09-30 | 7.0 million | 278000 |
| 2023-06-30 | - | 249000 |
KZR
Price: $0.70
52 week price:
Earnings Per Share: -1.40 USD
P/E Ratio: -0.79
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 409400
Market Capitalization: 56.2 million